✦ LIBER ✦
Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (Filgrastim) for treatment of advanced breast cancer
✍ Scribed by H. H. van Ojik; R. Repp; Gerard Groenewegen; Thomas Valerius; Jan G. J. van de Winkel
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 332 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.